Jingdong Zhang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure (NCT07311408) | Jingdong Zhang | 2026-01-01 |
Track Jingdong Zhang automatically
Every clearance here is in the API, with alerts when new ones post.